BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8777844)

  • 1. Tear and saliva ferning tests in Sjögren's syndrome (SS).
    Maragou M; Vaikousis E; Ntre A; Koronis N; Georgiou P; Hatzidimitriou E; Sotsiou F; Dantis P
    Clin Rheumatol; 1996 Mar; 15(2):125-32. PubMed ID: 8777844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of saliva ferning test in diagnosis of Sjögren's syndrome].
    Ding L; Tang Y; Lu Q
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 May; 36(3):174-6. PubMed ID: 11812334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of the saliva ferning test in diagnosis of Sjögren's syndrome].
    Puszczewicz M; Zimmermann-Górska I; Białkowska-Puszczewicz G
    Pol Arch Med Wewn; 2002 Jan; 107(1):13-7. PubMed ID: 12046339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tear mucus ferning in patients with Sjögren's syndrome.
    Vaikoussis E; Georgiou P; Nomicarios D
    Doc Ophthalmol; 1994; 87(2):145-51. PubMed ID: 7835183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity of the saliva ferning test for the diagnosis of dry mouth in Sjögren's syndrome.
    el-Miedany YM; el-Hady SM; el-Baddin MA
    Rev Rhum Engl Ed; 1999 Feb; 66(2):73-8. PubMed ID: 10084165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Light microscopy of dried saliva in the evaluation of xerostomia of the sicca syndrome. A preliminary report.
    Andonopoulos AP; Tzanakakis GN; Christophidou M
    J Rheumatol; 1992 Sep; 19(9):1390-2. PubMed ID: 1433006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and risk factors of neurological involvement in Sjögren's syndrome.
    Ye W; Chen S; Huang X; Qin W; Zhang T; Zhu X; Zhu X; Lin C; Wang X
    BMC Neurosci; 2018 Apr; 19(1):26. PubMed ID: 29703151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilocarpine and artificial saliva for the treatment of xerostomia and xerophthalmia in Sjögren syndrome: a double-blind randomized controlled trial.
    Cifuentes M; Del Barrio-Díaz P; Vera-Kellet C
    Br J Dermatol; 2018 Nov; 179(5):1056-1061. PubMed ID: 29432648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal Fatty Acid-Binding Protein: A Novel Marker in the Diagnosis of Dry Eye Disease in Sjögren Syndrome.
    Shinzawa M; Dogru M; Den S; Ichijima T; Higa K; Kojima T; Seta N; Nomura T; Tsubota K; Shimazaki J
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lactoferrin tear test in the diagnosis of Sjögren's syndrome.
    Da Dalt S; Moncada A; Priori R; Valesini G; Pivetti-Pezzi P
    Eur J Ophthalmol; 1996; 6(3):284-6. PubMed ID: 8908435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Sicca Symptoms Inventory for clinical studies of Sjögren's syndrome.
    Bowman SJ; Booth DA; Platts RG; Field A; Rostron J;
    J Rheumatol; 2003 Jun; 30(6):1259-66. PubMed ID: 12784400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interdisciplinary, Comprehensive Oral and Ocular Evaluation of Patients with Primary Sjögren's Syndrome.
    Tashbayev B; Rusthen S; Young A; Herlofson BB; Hove LH; Singh PB; Rykke M; Aqrawi LA; Chen X; Utheim ØA; Utheim TP; Palm Ø; Jensen JL
    Sci Rep; 2017 Sep; 7(1):10761. PubMed ID: 28883442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome.
    Vitali C; Moutsopoulos HM; Bombardieri S
    Ann Rheum Dis; 1994 Oct; 53(10):637-47. PubMed ID: 7979575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sjögren's syndrome: diagnosis and systemic manifestations].
    Hatron PY
    Rev Prat; 2012 Feb; 62(2):221-4. PubMed ID: 22408869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reproducibility of the classification of ocular ferning patterns in Sjogren's syndrome patients].
    Felberg S; Cordeiro H; Sato EH; Martini Filho D; Nishiwaki-Dantas MC; Endo RM; Dantas PE
    Arq Bras Oftalmol; 2008; 71(2):228-33. PubMed ID: 18516423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of classification criteria of Sjogren syndrome in patients with sicca symptoms: Real-world experience at a medical center.
    Chiu YH; Szu-Hsien Lee T; Chao E; Chen IF; Liu FC; Chiu CH; Chen HC; Chang DM; Chu SJ; Kuo SY; Lu CC
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 3):480-487. PubMed ID: 31303456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The frequency of sicca symptoms and Sjögren's syndrome in patients with systemic sclerosis.
    Kobak S; Oksel F; Aksu K; Kabasakal Y
    Int J Rheum Dis; 2013 Feb; 16(1):88-92. PubMed ID: 23441777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Dry oral and ocular manifestations and autoantibodies characteristic of primary Sjögren's syndrome in multiple sclerosis".
    Hora JSI; da Silva MCR; Braga CLS; Loureiro AM; Alves ATNN; Lourenço SQC; Vasconcelos CCF
    Mult Scler Relat Disord; 2022 Jun; 62():103783. PubMed ID: 35452962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
    Petrone D; Condemi JJ; Fife R; Gluck O; Cohen S; Dalgin P
    Arthritis Rheum; 2002 Mar; 46(3):748-54. PubMed ID: 11920411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral and ocular manifestations in Sjögren's syndrome.
    Kalk WW; Mansour K; Vissink A; Spijkervet FK; Bootsma H; Kallenberg CG; Roodenburg JL; Nieuw Amerongen AV
    J Rheumatol; 2002 May; 29(5):924-30. PubMed ID: 12022351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.